CICP launches fund aimed at making Indiana a chemistry hub
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
BiomEdit CEO Aaron Schacht talks about the strategy behind the round and the changes the animal health startup had to make to secure the money it needed to bring its first product to market,
The animal health startup had fundraising success in 2025, a year in which investment deals were hard to come by.
The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline of genetic medicines.
Ventyx is a San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis.
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.
Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Lewis sat down with IBJ to talk about his leadership style and the role of cycling in his life.
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
The Bloomington-based Applied Research Institute, which manages Heartland BioWorks, said the agreement will position Indiana as a “central nexus for biomanufacturing training and innovation.”
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
The move continues the Indianapolis-based drugmaker’s investments in age-related diseases.
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
The move leaves J&J focused on its pharmaceutical and MedTech segments, which make prescription drugs, contact lenses and technology to treat cardiovascular disease and help with surgeries.
Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.
The new vitamin D test, to be distributed from the Swiss-based company’s Indianapolis hub, is the first such test using a mass spectrometry-based system to receive regulatory approval in the U.S.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.